Anemia Flashcards
Pathophysiology of Anemia
Decreased iron-carrying capacity of blood
Iron-deficiency anemia
- caused by poor intake or blood loss (acute or chronic)
- treated with iron replacement
Folic Acid deficiency anemia
- Seen in alcoholism, chronic malnutrition, fad diets, and diets low in vegetables
- Drugs: Dilantin, sulfamethoxazole/trimethoprim, oral contraceptives, methotrexate
Pernicious anemia
- Vitamin B12 deficiency leads to macrolytic-normochromic anemia
- Vegetarians, vegans, genetic predisposition, autoimmune disease
Anemia: Goals of Treatment
Restore hemoglobin (Hgb) and red blood cell count to normal levels to maintain oxygen-carrying capacity of blood
Iron-Deficiency Anemia: Prevention and Treatment
Prevention:
- Adequate intake via iron-rich diet
- Monitor in periods of rapid growth (infancy, adolescence, pregnancy)
- Replacement in infants 1 mg/kg/day starting at 4 months (2mg/kg/day in preterm infants)
Treatment
- iron replacement based on age
- dose divided to 3 doses per day
Iron Deficiency Anemia: Monitoring & Outcome Evaluation
Monitoring
- Reticulocyte count 5-10 days after starting therapy
- Hgb, Hct, ferritin at 4 weeks, then at 3 months and then annually
Outcome Evaluation
- Return to normal Hgb, Hct, and ferritin levels should be determined
- If Hgb, Hct, ferritin do not return to normal levels, the patient should be evaluated for a source of blood loss in other pathology
Iron Deficiency Anemia: Patient Education
Importance of prevention with adequate iron intake in diet
Administration
- Empty stomach if tolerated
- Three times per day is best
- May cause constipation (may need a stool softener)
Folic Acid Deficiency Anemia: Risk groups
- Infants fed goat’s milk or powdered milk formula
- Vegetarians and vegans
- Pregnant women increases in daily requirement
- Patients with sprue, Crohn’s disease, giardial infections, and short bowel syndrome
- Patients taking drugs that affect folic acid absorption
Folic Acid Deficiency Anemia: Prevention & Drug Therapy
Prevention
- Adequate dietary intake
- Folic acid supplementation in pregnancy
Drug Therapy for deficiency
- Oral folic acid 1-2 mg/day for 4-5 weeks
- Hgb levels start to rise in a week
Women of childbearing age and pregnant women should consume 0.4 mg to 0.8 mg/day
Folic Acid Deficiency Anemia: Monitoring and Patient Education
Monitoring
- Follow Hgb/Hct in 4 weeks and then regularly
Education
- Need for folic acid
- Administration
Pernicious Anemia: Cause
Caused by inadequate vitamin B12
- Defective secretion of gastric intrinsic factor, which is necessary for vitamin B12 absorption
- Vitamin B12 malabsorption in 10%-30% of adults older than age 50 years because of reduced pepsin activity and gastric acid secretion
Pernicious Anemia: Prevention & Drug Therapy
Prevention
- eating foods high in vitamin B12 such as mollusks (e.g., clams), fortified breakfast cereals, liver, trout, salmon, milk, eggs
Drug Therapy
- Oral, IM, and intranasal vitamin B12 replacement
- Nutritional deficit: 1,000 mcg/day of cobalamin given until normal B12 levels
- Vitamin B12 therapy 1,000 mcg IM daily for 1 week followed by 100-1,000 mcg IM weekly for a month
- – Parenteral, nasal, or oral therapy: may be used once a patient’s B12 level return to normal
- – Parenteral: 1000 mcg of vitamin B12 IM monthly
- – Nasal: 500 mcg of cyanocobalamin weekly
- – Oral: 1000 mcg daily (least expensive)
Pernicious Anemia: Monitoring & Patient Education
Monitoring:
- Reticulocyte counts, Hgb & Hct, iron, folic acid, & vitamin B21 serum levels prior to treatment, at 5-7 days of therapy, then frequently until Hgb & Hct are normal
- Monitor potassium levels
- Liver function tests every 2-4 weeks to monitor hepatotoxicity
Patient Education
- Disease process and need for lifelong therapy
- Vitamin B12 therapy regimen
- Monitoring
Anemia of Chronic Disease
Occurs as a result of a disease process
Older adults
Patients with renal failure, osteomyelitis, TB, rheumatoid diseases, hepatitis, carcinoma, myeloma, lymphoma, and leukemia at risk
Anemia of Chronic Disease: Treatment
- If associated with chronic renal failure or zidovudine-treated HIV: epoetin alfa 50 to 100 units/kg in adults and 50 units/kg in children dosed 3 times per week
- Epoetin alfa dose titrated to keep Hgb level between 1012 g/dL
- Dosage increased by 25% if Hgn is less than 10
- Epoetin alfa dose decreased by 25% if Hgb approaches 12 or increases greater than 1 in any 2 week period
Sickle Cell Anemia: Pharmacodynamic & Prevention
- Universal newborn screening
- Autosomal recessive genetic disorder
- HgbS which distorts into sickle shaped RBC
- – Sickled cells obstruct microvessels
Prevention
- Immunizations
- Hydration
Sickle Cell Anemia: Treatment
Multivitamin infusion daily
Evaluate for vitamin D deficiency
Prophylactic penicillin
Hydroxyurea (Droxia, Hydrea)